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Abstract
Cannabis is the most popular illegal drug. Its legal status is typically justified on
the grounds that cannabis use has harmful consequences. Empirically investigating
this issue has been a fertile topic for research in recent times. We provide an
overview of this literature, focusing on studies which seek to establish the causal
effect of cannabis use on health, education and labor market success. We conclude
that there do not appear to be serious harmful health effects of moderate cannabis
use. Nevertheless, there is evidence of reduced mental well-being for heavy users
who are susceptible to mental health problems. While there is robust evidence
that early cannabis use reduces educational attainment, there remains substantial
uncertainty as to whether using cannabis has adverse labor market effects.
Keywords: cannabis use, health, education, labor market
∗Department of Economics, Tilburg School of Economics, The Netherlands; Department of Eco-
nomics, University of Melbourne, Australia and CEPR; email: vanours@uvt.nl.




Cannabis is the most popular illegal drug. Between 2.8 and 5.0 percent of the
world’s population aged 15-64 uses cannabis at least once a year. This corresponds
to between 130 and 230 million people (United-Nations (2013)).1 The sheer num-
ber of cannabis users is surprising given that cannabis supply and distribution
is prohibited globally, and use is a criminal offense in most nations. The legal
regime governing cannabis use is less strict in some countries. For example, the
Netherlands have quasi-legalized cannabis use; in the US, several jurisdictions have
made cannabis available for medical purposes (“medical marijuana”) and since 2014
cannabis is legal in two US states (Colorado and Washington although at the fed-
eral level cannabis use is still prohibited). In some Australian states and territories,
both growing cannabis for personal use and consuming cannabis has been reduced
to a civil offense via decriminalization (Reuter (2010)). Jurisdictions which take a
“soft” approach to cannabis are, however, the exception to the rule. By and large,
those who use cannabis do so under the threat of criminal prosecution. This policy
stance is typically justified on the grounds that cannabis use has harmful conse-
quences. Empirically investigating this issue has been a fertile topic for research in
recent times. The purpose of this paper is to review the evidence base accumulated
to date. We highlight the contributions from the economics literature. A distin-
guishing feature of this literature is that it seeks to determine the causal nature of
the relationship between cannabis use and its potential consequences.
A key concern voiced in policy debates on cannabis is that cannabis use has
harmful health effects. And while many studies in the epidemiology and medical
literature report a negative association between cannabis use and health, a causal
relationship running from cannabis use to poor health is not the only possible ex-
planations for this correlation. Two alternative explanations exist. First, there
may be common determinants of both cannabis use and poor health that have not
been accounted for. This case is often referred to as spurious correlation because
there is no direct relationship between cannabis use and health, only an indirect
one that operates via the common (unobserved) determinants. The second alter-
native explanation is that there is a causal relationship, but it runs from poor
health to cannabis use. For example, a cancer patient undergoing chemotherapy
may treat their nausea with cannabis. This explanation is called reverse causality.
Distinguishing between these three alternative explanations is necessary in order
to develop policies which are effective at achieving their goal. Clearly, reduced
cannabis use will lead to an improvement in health only if the alternative explana-
tions of spurious correlation and reverse causality can be ruled out. Herein lies the
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significance of the contributions from economics.
While the debate about cannabis often focuses on its direct health effects,
cannabis use may also have indirect health effects. For example, cannabis use
may adversely impact on educational attainment or labor market success. Previous
research has found that that both educational attainment and income are impor-
tant determinants of health outcomes. Consequently, if cannabis use impacts these
outcomes, it will indirectly impact on health. For this reason we discuss studies
that investigate the educational and labor market consequences of cannabis use in
addition to those that analyze the health consequences. We do not, however, survey
the contributions made by economists on the interaction between drug policy and
drug use. Excellent surveys on this topic have been provided by MacDonald (2004),
Pudney (2010), and Caulkins et al. (2012).2 Similarly, we do not survey studies on
the “stepping-stone” or “gateway” hypothesis, which posits that cannabis use leads
to use of hard drugs such as cocaine or heroine. A gateway effect could exacerbate
potential effects of cannabis use through the use of other more dangerous drugs.
However, as for example MacDonald (2004) indicates, empirical research suggests
that the relation between early cannabis use and later hard drug use derives from
association through unobserved characteristics rather than through a direct causal
path.
Before we proceed to surveying the literature on the relationship between cannabis,
health, education and labor market outcomes, we provide context in section 2 by
discussing the various indicators of the prevalence of cannabis use and characteriz-
ing cannabis use in terms of intensity and dynamics of use. In section 3 we present
and discuss a number of recent studies on the effects of cannabis use on physical
health and mental health. In addition to the direct health effects, in section 4 we
also consider indirect health effects that occur through the impact of cannabis use
on education. In section 5 we consider the relationship between cannabis use and
labor market success. Section 6 concludes.
2 Characteristics of cannabis use
2.1 Prevalence and intensity of cannabis use
Table 1 reports detailed information on the intensity of cannabis use distinguishing
between lifetime use, last year use, last month use and daily use (in last month).
There is substantial variation in each of these measures of use both across countries
and within countries. The variation across countries is demonstrated by comparing
Hungary, where just 8.5% of the population aged 15-64 have used cannabis in their
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lifetime, with the US where 42% of those aged 12 or older have used cannabis in
their lifetime. The within-country variation is also large. In the Netherlands for
example, 22.6% of the population aged 15 to 64 have used cannabis in their lifetime
but only 5.4% have done so in the last year and 3.3% in the last month. Daily or
almost daily use is relatively high in France, Spain and the US, but it is striking
that in all other countries less than 1% of the population use cannabis on a daily
basis. Apparently, cannabis use is not very addictive for a substantial part of the
users (see Van Ours (2005) for details). Also, the numbers in Table 1 illustrate that
although a substantial part of the population have used cannabis, the prevalence
of heavy use in the population is quite low.
2.2 Dynamics in cannabis use
While the prevalence of past month or past year cannabis use is a commonly cited
measure of the extent of its use, and one that is easily comparable to other measures
of risky behavior or adverse outcomes, it is nonetheless a rather crude metric and
one that that may be considered misleading for at least two reasons. First, cannabis
use is concentrated amongst young individuals. It may therefore be argued that
the prevalence of use in the population at risk of using (those aged 15-25 for ex-
ample) is more informative about the extent of cannabis use than the prevalence
in the population aged 15-64. The second reason that simple prevalence rates may
be considered misleading is that this measure provides no information on lifetime
trajectories and patterns of use in general, and harmful use in particular. Although
a significant proportion of the population will have tried cannabis at some point in
their life, many use for a short period only. Some use it on a regular basis but at
low, recreational levels, akin to drinking a beer every now and then. Others will
become long term heavy users. Moreover, it is widely believed that early onset of
cannabis use has especially harmful effects on health and life outcomes. Therefore,
in this section we provide cross-country information on the dynamics of cannabis
use, including age of at first use and the duration of use.
Figure 1 shows typical patterns in the dynamics of cannabis use for a sample of
Amsterdam residents (Van Ours (2005)), for individuals living in Australian house-
holds, and for individuals from the US interviewed in the National Longitudinal
Survey of Youth 1997 (NLSY97). The information for Amsterdam and Australia
related to individuals aged 25-50 when surveyed, while the NLSY97 data are on
individuals who were 24-29 the last time they were surveyed. The top-left graph
shows that people start using cannabis between age 15 and 25, with clear peaks
at age 16, 18 and 20. If uptake has not occurred before age 25, it is very unlikely
4
to occur later on in life. The top-right graph shows the cumulative starting prob-
ability, which increases between age 15 and 25 and then levels off at older ages at
a prevalence of between 50 and 60 percent. The bottom-left graph shows that in
Amsterdam and Australia about 20 percent of the cannabis users stop using within
a year of starting. The bottom-right graph shows that many consumers stop using
after a couple of years, but even 20 years after they started between 30 and 40
percent are still using cannabis. Based on these dynamics three groups of individu-
als can be distinguished, abstainers, experimentalists and persistent users some of
whom are recreational users while others are addicts. It is noteworthy that despite
having very different legal regimes governing cannabis use, these three countries
exhibit very similar patterns in the dynamics of cannabis use.
3 Direct health effects of cannabis use
There has been no recorded case of mortality due to cannabis overdose and it was
not until the 1990’s that cannabis was first recognized as a drug of dependence
(Roffman and Stephens (2006)).3 Nevertheless, among inexperienced users and
experienced users following heavy consumption, cannabis intoxication may result in
anxiety, panic and psychotic symptoms.4 Research has investigated the potential for
cannabis use to impact on mortality and morbidity through road traffic accidents,
and mental and physical health.
3.1 Physical health
The vast majority of what is known about the impact of cannabis on physical health
comes from the epidemiology literature, with economists making only a small num-
ber of contributions. Epidemiological studies investigate the risk to physical health
from acute use (cannabis intoxication) and from chronic use. In terms of acute use,
the focus has been on the question of whether cannabis intoxication increases the
risk of road traffic accidents.5 Experimental studies based on driving simulators or
driving courses tend to find that cannabis users compensate for impairment while
intoxicated by driving more safely. Given that participants in the experiments are
aware they are being observed and assessed, this line of research may not be very
informative about the way cannabis impaired drivers actually drive while intoxi-
cated, and hence the impact of cannabis use on the risk of road traffic accidents.
The epidemiology literature views culpability and case controlled studies as pro-
viding better evidence on the risk of a traffic accident due to cannabis intoxication
(Sewell et al. (2009)). Amongst the challenges faced by these studies, however, is
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that the relationship between blood serum THC levels and impairment is poorly
understood.
Culpability studies assign drivers who have crashed according to their degree
of responsibility for the crash, and then seek to determine whether cannabis use
is more prevalent in the group of drivers culpable for crashes. In their review of
the literature, Sewell et al. (2009) report contradictory findings from culpability
studies. They identify measurement error in allocating individuals to the cannabis
impaired versus non-impaired group as a significant issue in this literature.6 As
with culpability studies, case control studies use information from administrative
databases on crashes involving a fatality and compare the prevalence of cannabis use
amongst drivers injured or killed in traffic accidents with that in a suitably chosen
control group. Studies of the impact of cannabis use on traffic accidents using
the case control methodology have produced conflicting findings. As discussed in
the assessment of this literature by Sewell et al. (2009), this may be attributable
to weaknesses in the selection of controls, as well measurement errors associated
with using the metabolite carboxy-THC, which is present in ones system days after
the consumption of cannabis, to determine cannabis intoxication. In addition to
the challenges presented for culpability and case control studies discussed above,
there remains the issue of unobserved common founders that potentially determine
both the decision to drive while intoxicated and the decision to use cannabis. This
challenge is yet to be adequately addressed within the epidemiology literature.
A recent contribution from the economics literature takes a somewhat different
approach to understanding the relationship between cannabis use and road traffic
fatalities. Specifically, Anderson et al. (2013) investigate the impact of laws that
legalize the use of cannabis for medical purposes on road traffic fatalities. They find
that in the first full year after coming into effect, legalization is associated with an
8-11 percent decrease in road traffic fatalities. Importantly, the reduction is larger
for fatalities involving alcohol.7 They also show that legalization is associated with
a reduction in the price of cannabis and a reduction in consumption of alcohol. As
legalization of cannabis for medical purposes does not typically permit the use of
cannabis in public, the authors suggest their results are consistent with consumption
of cannabis at home being substituted for consumption of alcohol at bars and
restaurants. Thus the reduction in road fatalities is due to a net reduction of
driving while intoxicated by alcohol or cannabis rather than safer driving under the
influence of cannabis compared to alcohol.
Studies investigating the physical health risks of chronic cannabis use are gen-
erally interested in its impact on diseases such as cancer and emphysema, which
take many years to develop. As a consequence, they tend to focus on heavy long
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term use. Given that smoking is the typical mode of administration for cannabis
use, one of the concerns about chronic cannabis use is that it may increase the risk
of cancer of the lungs, upper respiratory tract, head and neck. The research from
epidemiology on the effect of cannabis use on these cancers does not provide clear
cut evidence with studies reporting mixed findings (Mehra et al. (2006); Hashibe
et al. (2005)). The effect of cannabis use on the risk of emphysema has also been
examined. For example, Tashkin (2001) followed individuals in the US over eight
years and found that cannabis smoking did not increase the risk of emphysema.
Similarly, no increased risk of emphysema was found in a group of heavy cannabis
only smokers in New Zealand (Aldington et al. (2007)).
There are only a handful of studies in economics that investigate the impact of
cannabis use on physical health. A key contribution of this small literature is that
the studies tend to use techniques designed to tease out causal effects. Williams
and Skeels (2006) use an Instrumental Variable (IV) approach to identify the causal
effect of cannabis use on self assessed health status using data representative of
the Australian non-institutionalized population, and accounting for endogenous
cigarette smoking. They find that, after accounting for the effect of cigarette smok-
ing, the probability of being in very good or excellent health is 8% lower amongst
those who consumed cannabis in the past year compared to those who had not
and 18% lower for those who reported weekly use. Van Ours and Williams (2012)
use a discrete factor approach to account for selection into cannabis use in their
investigation into the mental and physical health effects of cannabis consumption.
Their set-up combines a bivariate mixed proportional hazard (BMPH) model for
cannabis uptake and quitting with linear models for mental and physical health
where unobserved heterogeneity for all four outcomes is drawn from a multivariate
discrete distribution. Their results suggest that cannabis use reduces the physical
well-being of men. Although statistically significant, the magnitude of the effect
of using cannabis is found to be small. This suggests that while cannabis use does
have a detrimental effect on overall health, the magnitude of this effect is not large
for the typical user.
While the strength of the contributions from economics in this area is the atten-
tion given to distinguishing causality from correlation, it is important to acknowl-
edge that one cannot “prove” causality. Each statistical technique used to identify
a causal effect ultimately relies on an assumption that is untestable. Therefore,
in evaluating the evidence contributed by the economic studies, one must consider
the credibility of the assumptions employed to identify the causal effect. The two
approaches used in the studies discussed above, IV and a bivariate proportional haz-
ard model employing a discrete factor approach, are both commonly used in the
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relevant economics literature, and for this reason we provide a detailed discussion
of identifying assumptions for these methods below.
The untestable identifying assumption for IV based strategies is that the set of
instruments is validly excluded from the equation for the outcome of interest. In the
paper by Williams and Skeels (2006), the instrument set consists of family structure,
state policies relating to cannabis and cigarette use, and attitudinal variables. As
noted by Dee and Evans (2003), the use of cross-sectional variation in policies that
target substance use in order to identify the effect of substance use on outcomes
of interest can be problematic if the policy variables themselves are correlated
with unobserved state specific characteristics that also determine the outcomes of
interest.
Unlike Instrumental Variables estimation, the bivariate mixed proportional haz-
ard model (which uses the discrete factor approach to model unobserved hetero-
geneity) does not require exclusion restrictions in order to identify the causal effect
of interest, and it is robust to misspecication of the functional form of the joint
distribution of unobserved heterogeneity compared to methods that require para-
metric distributional assumptions. As discussed by Van Ours and Williams (2012),
identification of their four equation system with correlated errors comes from the
timing of events and the assumption of mixed proportional hazard rates in the
cannabis dynamics part of the model, as well as distributional assumptions in the
health production functions.8 This needs to be considered in evaluating the findings
of this study (and those based on this approach more generally). A further issue
to considered for this paper is that, while the analysis accounts for endogeneity of
cannabis arising through common unobserved confounders, the data used are not
rich enough to account for the potential for reverse causality, as arises in the event
that ill health leads to cannabis use. To the extent that reverse causality occurs,
this paper will tend to overstate the impact of cannabis use on health.
3.2 Mental health
As with physical health, the majority of research on the relationship between
cannabis use and psychological well-being has been contributed by the epidemi-
ology literature. In fact, the number of epidemiology and medical studies in this
area is so large that there are now quite a few overview studies that summarize the
literature’s main findings. The main findings in the overview studies are discussed
below and summarized in Table 2.9
In a meta analysis, Degenhardt et al. (2003) find a modest but significant asso-
ciation between heavy use of cannabis and later depression. Arseneault et al. (2004)
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report that cannabis use is neither a necessary nor a sufficient condition for the de-
velopment of psychosis. Kalant (2004) conclude that for the relationship between
cannabis use and psychiatric problems, there is more evidence for causality than for
reverse causality. However, while Macleod et al. (2004) find evidence of association
between cannabis use and psychosocial harm, they conclude that the causal nature
of the relationship is far from clear. Henquet et al. (2005) find there is a causal
effect of cannabis use on schizophrenia but that it is not very large and the mech-
anism underlying the causal effect is unclear. Both Semple et al. (2005) and Hall
(2006) conclude that there is an association between psychosis and cannabis use
but whether there is a causal relationship remains unclear and controversial. Moore
et al. (2007) perform a meta-analysis of the longitudinal studies investigating the
impact of cannabis use on psychotic symptoms and disorders. They report a pooled
odds ratio for psychotic symptoms or disorders in those who had ever used cannabis
of 1.4 times the risk of someone who had never used cannabis. Nonetheless, there
has been much debate as to whether the findings of this literature reflect a causal
relationship between cannabis use and psychotic symptoms. Concerning depression
and cannabis use Hall and Degenhardt (2009) conclude that the epidemiological re-
search on this association is mixed. Finally, both McLaren et al. (2010) and Werb
et al. (2010) find there is insufficient evidence to conclude that a causal effect from
cannabis use to psychosis exists.
In epidemiological studies based on longitudinal data, the issue of reverse causal-
ity is addressed by only considering those for whom cannabis use preceded the onset
of mental health problems, or by controlling for pre-existing mental health problems
in studying the contemporaneous impact of cannabis use on mental health. These
studies then attempt to identify the causal effect of cannabis use by controlling for
observed factors that may be a source of confounding (for example, Fergusson and
Horwood (1997)).10 However, as noted by Pudney (2010), the potential for unob-
served common confounding factors makes inference regarding the causal impact of
cannabis use difficult.
Studies from economics on the question of whether using cannabis reduces psy-
chological well-being recognize and seek to address the issue of omitted confounding
factors (see Table 3 panel a for an overview). Van Ours and Williams (2011) and
Van Ours and Williams (2012) use cross-sectional data from Australia and the
Netherlands respectively to study the impact of cannabis use on mental health.
Even though they have cross-sectional data, using retrospective questions of the
age of uptake of cannabis and sometimes the age of last use, they are able to
model cannabis use dynamics. Van Ours and Williams (2011) account for common
unobserved factors affecting mental health and cannabis consumption by modeling
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mental health jointly with the dynamics of cannabis use and employing the discrete
factor approach. They find that using cannabis increases the likelihood of mental
health problems, with current use having a larger effect than past use. The esti-
mates suggest a dose response relationship between the frequency of recent cannabis
use and the probability of currently experiencing a mental health problem. As dis-
cussed above, Van Ours and Williams (2012) account for selection into cannabis
use and shared frailties in mental and physical health using a bivariate mixed pro-
portional hazard model for cannabis use dynamics and linear equations for mental
and physical health combined with the discrete factor approach o accounting for
correlated unobserved heterogeneity. Their results suggest that cannabis use re-
duces the mental well-being of men and women. Although statistically significant,
the magnitude of the effect of using cannabis on mental health is found to be small.
In order to address the issue of reverse causality, longitudinal information about
the age of onset of mental health problems and cannabis uptake is required. The
only paper in the economics literature with access to sufficiently rich data to address
the potential for reverse causality is by Van Ours et al. (2013). This study uses
the Christchurch Health and Development Study, a thirty year follow up study of
a birth cohort born in Christchurch New Zealand to investigate the relationship
between the uptake of regular cannabis use and the onset of suicidal ideation. In
order to account for reverse causality as well as unobserved common confounders
the authors adopt a fully simultaneous BMPH framework. Specifically, in addition
to cannabis use entering the hazard rate for suicidal ideation and suicidal ideation
entering the hazard rate for cannabis uptake, the unobserved heterogeneity terms
in the hazard rates are assumed to be drawn from a bivariate discrete distribution.
The results suggest that intensive cannabis use – at least several times per week –
leads to a higher transition rate into suicidal ideation for males who are vulnerable
to suicidal ideation. Importantly, they find no evidence that suicidal ideation leads
to regular cannabis use for either males or females. As with the earlier studies that
use the BMPH approach, the identification of causal effects in this study is based
on the timing of events and the assumption of proportional hazards.
Overall, the three studies from economics suggest that cannabis use has a neg-
ative effect on psychological well-being, with the magnitude of the effect generally
greater at higher intensities of use. This finding is robust to accounting for reverse
causality, common time invariant confounders and shared frailties between mental
and physical health.
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4 Cannabis use and education
There is substantial evidence from the epidemiology literature that early cannabis
use is associated with lower levels of education (Macleod et al. (2004), Lynskey and
Hall (2000)). However, while longitudinal prospective studies are able to rule out
academic failure causing cannabis use, the issue of omitted confounding common
factors remains a potential threat to a causal interpretation. For example, conduct
problems is an important risk factor for cannabis use as well as reduced educational
success (Fergusson et al. (1993); Pedersen et al. (2001)). Failing to account for the
impact of conduct problems on educational success leads to endogeneity of cannabis
use. As with the impact of cannabis use on physical and mental health, this issue of
the potential for endogeneity of cannabis use is addressed in the economics literature
on cannabis use and educational attainment (see panel b of Table 3).11
The method of Instrumental Variables (IV) is used to account for the endo-
geneity of cannabis use when examining its impact on education by Register et al.
(2001), Roebuck et al. (2004) and Chatterji (2006). Using data on males from
the NLSY, Register et al. (2001) examine the impact of drug use by the age of 18
on the number of years of education completed. They find that on average, male
adolescent drug use is associated with a reduction of around 1 year in educational
attainment, where this result is driven by the whites in the sample. Roebuck et al.
(2004) use two waves from the National Household Survey on Drug Abuse (1997
and 1998) to study the impact of cannabis use on high-school dropout, distinguish-
ing between chronic cannabis use (weekly or more) and non-chronic cannabis use
(less than weekly). Their results (from estimating univariate probit models) sug-
gest that chronic cannabis use increases the probability of dropout by between 1.34
and 1.97 percentage points while non-chronic cannabis use reduces it by between 0
and 0.07 percentage points.12 Chatterji (2006) exploits the unusually rich National
Education Longitudinal Study to examine the impact of past month cannabis use in
10th and 12th grade on subsequent years of education completed. The IV estimates
of the impact of cannabis use are generally negative, statistically indistinguishable
from zero, and not statistically different from the OLS estimates. Based on the
OLS estimates, the author concludes that cannabis use in 10th grade reduces edu-
cational attainment by around 0.2 of a year, and cannabis use in 12th grade reduces
it by 0.3 of a year. As discussed previously, identification of causal effects using
the IV estimator rests on the untestable assumption that the set of instruments is
validly excluded from the equation for the outcome of interest.13
Van Ours and Williams (2009) address the question of whether cannabis up-
take is more harmful for education outcomes at some ages compared to others,
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and whether the effect differs across gender. The authors use individual level data
from Australia to estimate a bivariate mixed proportional hazard model for starting
cannabis use and leaving education. The endogeneity of cannabis use arising from
common unobserved variables is addressed using the discrete factor approach to
modeling the joint distribution of unobserved heterogeneity determining the haz-
ard for leaving education and the hazard for starting cannabis use. In terms of
the impact of cannabis use on school leaving, they find that initiating cannabis use
at younger ages leads to larger increases in the rate of school leaving compared to
initiation into cannabis use at older ages. In addition to accounting for endogene-
ity arising from common unobserved confounders, the authors also investigate the
potential for reverse causality. Their findings are robust to accounting for this addi-
tional source of endogeneity.14 As discussed above, identification of causal effects in
the BMPH model relies on the timing of events (school leaving, cannabis uptake) as
well as the (untestable) assumption of proportional hazard rates for school leaving
and cannabis uptake, and this caveat should be borne in mind in interpreting and
assessing the findings.
Rather than using a statistical approach to account for the endogeneity of
cannabis use arising from common confounders, McCaffrey et al. (2010) attempt
to directly account for all factors systematically related to cannabis use that may
also impact on education in their analysis of the impact of heavy and persistent
cannabis use on high-school dropout. Using data from a panel study of 7th grade
students from South Dakota between 1997 and 2004, the authors find that the
positive association between cannabis use and dropout is to a large extent due to
differences in characteristics and behaviors measured before cannabis use started.
The identifying assumption in this analysis is that after conditioning on observable,
there exist no unobservable common confounders. This assumption is untestable,
and this caveat should be kept in mind when assessing the interpreting this study’s
findings (Pudney (2010).15
5 Cannabis use and labor market success
A significant contribution of the early economic studies on the relationship between
drug use and labor market success is their formalization of the behavioral relation-
ship between these outcomes and recognition of the potential endogeneity of the
decision to use drugs. Two separate avenues through which endogeneity of drug use
may arise were identified: reverse causality and omitted variables. Reverse causal-
ity occurs because a large component of a person’s income is labor market earnings.
Therefore, an increase in income (via an increase in wages or employment) will lead
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to a greater demand for drugs (if drug use is a normal good). A second reason
to suspect that drug use may not be exogenous to labor market outcomes in a
statistical sense is omitted variables.
An example of an important unobserved determinant of wages or employment
that also influences the decision to use drugs is an individual’s health status. Indi-
viduals who are in worse health may be more likely to use drugs to address their
symptoms. Those in ill health may also be more likely to choose jobs that are less
demanding and more flexible, trading off these attributes for lower wages. This
may give rise to a negative correlation between drug use and wages even if drug use
is not causally related to wages. Similarly, individuals with strong preferences for
leisure may also be more likely to use drugs if drug use and leisure are complements
in the production of euphoria. Such a relationship would produce a negative cor-
relation between drug use and labor supply even in the absence of a causal effect
of drug use on labor supply.
The first wave of studies into the impact of drug use on wages and employment
use an Instrumental Variable approach to estimating causal effects. An overview of
the main characteristics of the first wave of studies in which the health effects are
measured indirectly is provided in Panel c1 of Table 3. Three of these studies draw
on data on 18-27 year olds from the 1984 cross-section of the National Longitudinal
Survey of Youth (NLSY) and all three studies found evidence that, rather than
reduce wages as theory predicts, drug use increases wages.
The estimated magnitudes of the wage effects from these studies are quite large.
For example, Kaestner (1991) estimates that males who have tried cannabis earn
18% more than otherwise similar males who have not tried cannabis, Register and
Williams (1992) estimate that using cannabis on one more occasion per month in-
creases hourly wages by 5%, and Gill and Michaels (1992) find that drug users
earn about 4% more per hour than non-users. Register and Williams (1992) and
Gill and Michaels (1992) also report results that show that the probability of being
employed is reduced by cannabis use and drug use, respectively. It is noteworthy
that very little (and sometimes no) discussion of identifying assumptions is found
in these early studies, and many of the exclusion restrictions could be considered
questionable.16 Given this, and the current state of knowledge regarding the impor-
tance of the validity assumption and the performance of IV when instruments are
weak, one might reasonably view the findings of these early papers with caution.
A more cautious interpretation of the evidence regarding cannabis use and labor
market outcomes is also suggested by Kaestner (1994a,b), who concludes that drug
use does not have a systematic impact on labor supply or wages.
The counter-intuitive and inconsistent findings of the above studies motivated
13
a second wave of economic research into the impact of drug use on wages and labor
supply. Panel c2 of Table 3 gives an overview of the main characteristics of the
second wave of studies based on data from the United States (Burgess and Propper
(1998), Zarkin et al. (1998), French et al. (2001), DeSimone (2002), Conti (2010)),
Britain (MacDonald and Pudney (2000), Conti (2010)) and the Netherlands (Van
Ours (2006), Van Ours (2007)). This wave of research, defined as those studies
published from 1998 onwards, generally seek to improve on the earlier work in
one or more of the following three main ways. First, they may seek to determine
whether there is a dose-response relationship between drug use and labor market
outcomes. Many argue that unlike heavy or chronic drug use, low or moderate drug
use is unlikely to cause harm, and it is therefore important to distinguish between
different intensities of use when examining the impact of drug use on labor market
outcomes. Second, these studies often raise the issue of timing. If heavy drug use
lowers productivity, is its effect immediate? Or is only persistent long term use
harmful? Even if its effect is immediate, it may take time for an employer to notice
and to take action. Consequently, any effects of heavy use may be more apparent in
samples of older people. In order to assess the possibility that there are delayed or
cumulative effects of drug use on labor market outcomes, data sources that include
older individuals are typically used. There have also been efforts to separate out
the effects of past from current drug use. The third issue addressed by some of the
second wave of studies is the issue of the identification of the causal impact of drug
use. Approaches to this issue include: using lifetime rather than current drug use
as a way of minimizing the problem of reverse causality; using clinical definitions
of drug abuse; looking more carefully at the economic and statistical merits of
instruments; and using alternative econometric strategies that do not depend on
exclusion restrictions for identification.
Taken at face value, second wave studies tend to find evidence that non-problematic
use of drugs (light to moderate use, or the use of soft drugs) has no impact on labor
supply, measured by employment or hours worked, but that problematic use (heavy
use, or the use of hard drugs) does, although Burgess and Propper (1998); DeSi-
mone (2002); Zarkin et al. (1998) and Van Ours (2006) provide counter-examples.
Similarly, most of the second wave studies find that infrequent or non-problematic
drug use has no impact on wages, whereas problematic use does have negative wage
effects. Once again, there are also exceptions to this generalization, such as Mac-
Donald and Pudney (2000). It is again worth noting that, even among the more
rigorous of these studies, the interpretation of estimated effects as causal relies on
untestable identifying assumptions. Accordingly, any conclusions drawn form them
are subject to the same caveats and cautions discussed above.
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Given the conflicted nature of the empirical findings and questions surrounding
identification strategies, it is simply uncertain as to whether there are negative
labor market consequences of drug use in general, and cannabis use in particular.
Furthermore, it is unclear as to whether this literature should be interpreted as
reflecting a lack of robust evidence of a negative health effect of drug use (possibly
due to poor identification strategies), or as reflecting the presence of a productivity
improving effect of drug use that is confounding the negative health effects.
6 Discussion and conclusions
Despite a substantial number of epidemiological studies and a growing number of
econometric studies not much is known with any degree of certainty about the health
effects of cannabis use. Researchers agree on the association between cannabis use
and bad health. The issue is whether this association is causal, running from
cannabis use to health, or whether there are joint determinants unaccounted for
producing spurious correlation, or whether the causality runs in reverse, from poor
health to cannabis use. The main issue for researchers is that the optimal set-up
from a scientific point of view, a field experiment with randomization of cannabis
use, is not possible for at least two reasons. First and foremost, individuals will
know whether they received the “treatment” or not. Second, long term exposure
to cannabis would be required and this would be rather unethical in the event that
cannabis is harmful to one’s health.
The lack of econometric research that focuses on the question of causality is
surprising but likely to be related to the paucity of good data as a basis for the
research. Cannabis use is not a static phenomenon. On the contrary, dynamics in
use are very important. Within the population some individuals may start using
cannabis but others will abstain. Among those who have started using cannabis
there are individuals who will stop using and other individuals who will persist in
use. By and large, in the population there are never users, experimental users and
persistent users. Even within the group of persistent users there may be transitions
from high intensity of use to low intensity of use and vice versa. To understand the
dynamics of cannabis use, information is needed from the time that the individual
was first confronted with the choice to use a particular drug. Ideally, this informa-
tion would include how relevant circumstances change over time. Information that
could be important includes the family situation, experiences at school, changing
supply conditions, prices of drugs, etc. Unfortunately, this type of information is
most often not available.
When assessing the health effects of cannabis use some caveats are important.
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First, all health effects are established under a single policy regime, prohibition.
The legal status of a drug may affect the relationship between drug use and health.
Furthermore, by virtue of its legal status, is not easy to collect reliable data on
cannabis use. A second caveat concerns the way illegal drugs are consumed. Smok-
ing heroin for example is less dangerous than injecting heroin. Inhaling cannabis
that is vaporized is less dangerous than smoking cannabis. A third caveat is that
there have been important changes over time in cannabis. Specifically, the pro-
portions in which the two main psycho-active components of cannabis, delta-9-
tetrahydrocannabinol, which exaggerates psychotic effects, and cannabidiol which
moderates psychotic effects, is believed to have changed in recent years. While the
proportion of the former has increased, the proportion of later has decreased and
the net health effects of these changes are uncertain.
The impact of long term heavy cannabis use on the development of diseases such
as emphysema and cancer remains under debate, however only a small fraction of
the population will engage in cannabis use to this degree. There is very little known
about the impact of short-term use or long-term recreational use on health but the
limited available evidence does not indicate large effects. There has been growing
concern over the mental health effects of cannabis use. While the epidemiology
literature is quite mixed in whether there exists a causal effect of cannabis use on
mental health, the economics literature appears to produce a degree of consensus in
finding that the impact of cannabis use for moderate users is small, but that intense
use is likely to significantly reduce mental health and well-being, especially for those
vulnerable to mental health problems. In terms of the indirect health effects of
cannabis use, the literature has produced robust evidence that early cannabis use
reduces educational attainment. However, there remains insufficient evidence on
which to speculate on the labor market impact of using cannabis. Of course, these
conclusions are subject to the caveats regarding identifying assumptions.
Notes
1The annual prevalence of use of other illegal drugs is substantial smaller;
see for example Van Ours and Williams (2014) in their overview of the health
effects of illegal drug use. According to United-Nations (2013) between 14
an 21 million people used cocaine at least once a year, while for ecstasy the
number of past year users is estimated to be between 10 and 29 million. In-
formation on drug use is usually based on self-reported data from population
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surveys. Most empirical studies on the effects of cannabis use on health, edu-
cation and labor market success are based on this type of data. There is some
discussion on the reliability of this information. Pudney (2004) suggests that
misreporting of drug use may not be too serious. In particular misreporting
about cannabis use is less of a problem since it is a more socially acceptable
drug.
2For example, see Caulkins et al. (2012) for an excellent discussion sum-
marizing cannabis legalization design issues inspired by the recent debate in
California. In the debate on legalization of cannabis the demand relationship
between cannabis and alcohol is important. If the two are substitutes cannabis
legalization will lead to an increased use of cannabis but a drop in the use of
alcohol. Recent studies suggest that at least for young adults cannabis and al-
cohol are substitutes; see: DiNardo and Lemieux (2001), Crost and Guerrero
(2012) and Anderson et al. (2013).
3 It was recognized by the WHO in 1993 when the tenth revision of the
International Classification of Diseases was released and by the American
Psychiatric Association in 1994 when the Diagnostic and Statistical Manual
of Mental Disorders (4th Edition) was released.
4See Johns (2001) for a full discussion of this issue.
5Epidemiology has also contributed a number of papers investigating the
association between of cannabis use in pregnancy and birth outcomes that
offer mixed findings. See for example Hayatbakhsh et al. (2012). None of
these papers deal with the critical issue that using cannabis while pregnant is
a choice that is likely determined by unobserved factors that also determine
birth outcomes.
6This measurement error arises in one of two ways, depending on the
method used to determine intoxication. If cannabis intoxication is measured
using THC concentration in blood serum, the issue is classifying drivers who
were impaired by cannabis at the time of the crash as not impaired. This
occurs due to the delay that occurs between the time that the accident occurs
and the time that drivers blood is sampled combined with a lack of knowl-
edge about the speed at which cannabis is metabolized. As a consequence,
it is almost impossible to extrapolate backwards from the concentration of
THC at the time blood is drawn to be tested to THC levels at the time the
accident occurred. The second source of measurement error arises in stud-
ies that use the metabolite of THC, carboxy-THC, to establish cannabis use
among crashed drivers (Ramaekers et al. (2004)). Because this metabolite
can be detected in urine or blood days after cannabis has been used and long
after cannabis intoxication has ceased, studies using this metabolite will mis-
takenly classify some non-impaired drivers as impaired. Either of these two
types of measurement error will lead to an underestimate the impact of recent
cannabis on vehicular accidents.
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7 These range from 13.2 percent when they consider drivers with a blood
alcohol limit greater than zero, to 15.5 percent when they consider fatalities
resulting from a driver with a BAC of 0.10 or greater.
8Cannabis uptake and quitting are assumed to have a multivariate mixed
proportional hazard structure and identication of unobserved heterogeneity in
the health equations relies on their linear functional form and the assumption
that their idiosyncratic errors are normally distributed.
9Dependence is an important mental health effect of cannabis use that has
been omitted from this review. As discussed in Hall (2006), around 1 in 10
cannabis users meet the criteria for dependence. The risk of dependence is
much higher amongst daily users and those who start at an early age.
10Fergusson et al. (2002) is an exception in that they also control for unob-
served heterogeneity using fixed effects models.
11 Early studies that assume exogeneity of cannabis use are Yamada et al.
(1996) and Bray et al. (2000) who both find significant negative effects of
educational attainment.
12In tests not reported, the authors fail to reject the exogeneity of chronic
and non-chronic cannabis use in their model for high-school drop-out.
13The set of instruments used in Chatterji (2006) include state level cannabis
policy variables along with 2 school level variables related to the principal’s
perceptions and policies regarding drug use at the school the individual at-
tended for grade 8. Register et al. (2001) and Roebuck et al. (2004) use
religiosity to instrument cannabis use.
14Their results suggest that leaving formal education has no (statistically
significant) impact on the uptake of cannabis by males, but it does have a
small positive impact on the uptake by females. Nonetheless, the estimated
effect of initiation into cannabis on leaving formal education is not sensitive
to accounting for reverse causality.
15We note that the authors show that when peer effects related to cannabis
use are accounted for, own cannabis use no longer has a significant effect
on high-school drop-out. This is interpreted as suggesting that rather than
having a causal effect, cannabis use is correlated with unobserved common
confounders that lead to drop-out. An alternative interpretation is that peer
effects is the mechanism via which cannabis use effects high-school graduation.
16For example, non-wage income, frequency of religious attendance in 1979,
the number of delinquent acts in 1980 and current number of dependents
are used as instrument for cannabis use in the wage equations estimated by
Kaestner (1991); Register and Williams (1992) instrument cannabis use with
mothers education, fathers education, being raised in a Baptist or Methodist
household, attending religious services at least weekly, divorced in the past
18
year, and living in a central city; and Gill and Michaels (1992) instrument
substance use with the frequency of going to bars in the month before being
interviewed, an indicator for kept drinking after promising yourself not to,
income from illegal activities in 1980, and an indicator for being charged with
breaking the law in 1980.
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Table 1: Intensity of cannabis use; various countries (%)
Last Last Daily use
Survey Ever year month (last
Country year use use use month)
Australia 2007 35.4 10.3 5.8 –a
Austria 2008 14.2 3.5 1.7 0.3
Belgium 2008 14.3 5.1 3.1 0.9
Czech Republic 2008 34.2 15.2 8.5 0.8
Denmark 2010 32.5 5.4 2.3 0.5
England and Wales 2012 31.0 6.9 4.1 0.5
Finland 2010 18.3 4.6 1.4 0.2
France 2010 32.1 8.4 4.6 1.5
Germany 2009 25.6 4.8 2.4 0.4
Hungary 2007 8.5 2.3 1.2 0.3
Italy 2012 21.7 3.5 1.5 0.3
Netherlands 2005 22.6 5.4 3.3 0.8
Norway 2009 14.6 3.8 1.6 0.3
Poland 2010 17.5 9.6 5.4 0.4
Portugal 2007 11.7 3.6 2.4 1.1
Slovakia 2010 10.5 3.6 1.4 0.0
Spain 2011 27.4 9.6 7.0 2.5
US 2010 42.0 11.5 6.9 2.8
a: Last week use: 3.8%.
Note: Population age 15-64 except Australia 12 and older; Denmark 16-64; Hungary 18-
64; Italy 18-64; US 12 and older. Last month daily use = Prevalence of daily or almost
daily use (20 days or more in the last 30 days).
Sources: European countries – EMCDDA (European Monitoring Center for Drugs and
Drug Addiction); Australia – AIHW ( Australian Institute of Health and Welfare); US –





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 1: Dynamics in cannabis use in Amsterdam
a. Starting rates (left) and cumulative starting probability (right) by age
b. Quit rates (left) and cumulative quit probabilities (right) by duration of use in years
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